1. Opioid use disorder: developing depot buprenorphine products for treatment Publication: Silver Spring, MD : Center for Drug Evaluation and Research, February 2019 Subject(s): Buprenorphine -- therapeutic useDrug DevelopmentOpioid-Related Disorders -- drug therapyBuprenorphine -- administration & dosageClinical Trials as TopicDelayed-Action PreparationsNarcotic AntagonistsOpiate Substitution TreatmentHumansUnited StatesUnited States. Department of Health and Human Services.United States. Food and Drug Administration.
